Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients aged between 18 and 75~* Patients with essential hypertension {95 mmHg ≤ sitDBP\< 115 mmHg at the end of placebo run-in treatment period}~Exclusion Criteria:~* Patients with mean sitSBP ≥ 200 mmHg~* Patients with known hypersensitivity to Dihydropyridine or angiotensin II receptor blockers~* Patients with secondary hypertension or suspected secondary hypertension~* Patients with malignant hypertension~* Patients who have received any medications with possible interactions with study drugs~* Patients with uncontrolled diabetes~* Patients with severe heart disease or severe cerebrovascular disease~* Patients with clinically significant hematological test results, renal disease (serum creatinine) or liver disease (ALT or AST)~* Patients with a history of malignant disease~* Patients with a history of autoimmune disease~* Women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial~* Patients inappropriate to be included in study population due to other reasons at the discretion of the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).